Kalaris Therapeutics, Inc. SEC filings KLRS

Kalaris Therapeutics, Inc. has 699 filings in SEC EDGAR's recent list, going back to Oct 2, 2018. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.

Kalaris Therapeutics, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G Ownership over 5% (passive) Oct 26, 2026 —
4 Insider transaction Aug 28, 2026 Aug 27, 2026
4 Insider transaction Aug 3, 2026 Aug 1, 2026
3 Initial insider ownership Aug 3, 2026 Aug 1, 2026
3 Initial insider ownership Jul 27, 2026 Jul 27, 2026
4 Insider transaction Jul 20, 2026 Jul 20, 2026
3 Initial insider ownership Jul 20, 2026 Jul 20, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) May 22, 2026 —
4 Insider transaction May 22, 2026 May 20, 2026
4 Insider transaction Mar 23, 2026 Mar 19, 2026
144 Notice of proposed sale Mar 20, 2026 —
4 Insider transaction Mar 20, 2026 Mar 19, 2026
4 Insider transaction Mar 20, 2026 Mar 19, 2026
4 Insider transaction Mar 20, 2026 Mar 19, 2026
4 Insider transaction Feb 17, 2026 Dec 18, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 22, 2025 —
4 Insider transaction Dec 22, 2025 Dec 22, 2025
4 Insider transaction Nov 3, 2025 Nov 3, 2025
3 Initial insider ownership Nov 3, 2025 Nov 3, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
4 Insider transaction Apr 11, 2025 Apr 10, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
3 Initial insider ownership Apr 4, 2025 Apr 3, 2025
4 Insider transaction Mar 27, 2025 Mar 26, 2025
3/A Filing Mar 26, 2025 Mar 18, 2025
SCHEDULE 13D Ownership over 5% (active) Mar 25, 2025 —
3 Initial insider ownership Mar 25, 2025 Mar 18, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 20, 2025 —
4 Insider transaction Mar 18, 2025 Mar 18, 2025
4 Insider transaction Mar 18, 2025 Mar 18, 2025
4 Insider transaction Mar 18, 2025 Mar 18, 2025
4 Insider transaction Mar 18, 2025 Mar 18, 2025
4 Insider transaction Mar 18, 2025 Mar 18, 2025
4 Insider transaction Mar 18, 2025 Mar 18, 2025
3 Initial insider ownership Mar 18, 2025 Mar 18, 2025
3 Initial insider ownership Mar 18, 2025 Mar 18, 2025
3 Initial insider ownership Mar 18, 2025 Mar 18, 2025
3 Initial insider ownership Mar 18, 2025 Mar 18, 2025
3 Initial insider ownership Mar 18, 2025 Mar 18, 2025
3 Initial insider ownership Mar 18, 2025 Mar 18, 2025
3 Initial insider ownership Mar 18, 2025 Mar 18, 2025
4 Insider transaction Feb 24, 2025 Feb 21, 2025
4 Insider transaction Feb 24, 2025 Feb 21, 2025
4 Insider transaction Feb 24, 2025 Feb 21, 2025
144 Notice of proposed sale Feb 24, 2025 —
144 Notice of proposed sale Feb 24, 2025 —
144 Notice of proposed sale Feb 24, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
144 Notice of proposed sale Jan 24, 2025 —
144 Notice of proposed sale Jan 24, 2025 —
144 Notice of proposed sale Jan 24, 2025 —
4 Insider transaction Jan 13, 2025 Jan 10, 2025
4 Insider transaction Jan 13, 2025 Jan 10, 2025
4 Insider transaction Jan 13, 2025 Jan 10, 2025
144 Notice of proposed sale Jan 10, 2025 —
144 Notice of proposed sale Jan 10, 2025 —
144 Notice of proposed sale Jan 10, 2025 —
4 Insider transaction Dec 11, 2024 Dec 11, 2024
4 Insider transaction Nov 20, 2024 Nov 19, 2024
4 Insider transaction Nov 20, 2024 Nov 19, 2024
4 Insider transaction Nov 20, 2024 Nov 19, 2024
4 Insider transaction Nov 20, 2024 Nov 19, 2024
144 Notice of proposed sale Nov 19, 2024 —
144 Notice of proposed sale Nov 19, 2024 —
144 Notice of proposed sale Nov 19, 2024 —
144 Notice of proposed sale Nov 19, 2024 —
4 Insider transaction Nov 6, 2024 Nov 5, 2024
4 Insider transaction Nov 6, 2024 Nov 5, 2024
4 Insider transaction Nov 6, 2024 Nov 5, 2024
4 Insider transaction Nov 6, 2024 Nov 5, 2024
144 Notice of proposed sale Nov 5, 2024 —
144 Notice of proposed sale Nov 5, 2024 —
144 Notice of proposed sale Nov 5, 2024 —
144 Notice of proposed sale Nov 5, 2024 —
4 Insider transaction Oct 23, 2024 Oct 21, 2024
4 Insider transaction Oct 23, 2024 Oct 21, 2024
4 Insider transaction Oct 23, 2024 Oct 21, 2024
4 Insider transaction Oct 23, 2024 Oct 21, 2024
144 Notice of proposed sale Oct 22, 2024 —
144 Notice of proposed sale Oct 22, 2024 —
144 Notice of proposed sale Oct 22, 2024 —
144 Notice of proposed sale Oct 21, 2024 —
144 Notice of proposed sale Oct 21, 2024 —
144 Notice of proposed sale Oct 21, 2024 —
144 Notice of proposed sale Oct 21, 2024 —
SC 13G Ownership over 5% (passive) Oct 11, 2024 —
4 Insider transaction Oct 4, 2024 Oct 3, 2024
4 Insider transaction Oct 4, 2024 Oct 3, 2024
4 Insider transaction Oct 4, 2024 Oct 3, 2024
4 Insider transaction Oct 4, 2024 Oct 3, 2024
144 Notice of proposed sale Oct 3, 2024 —
144 Notice of proposed sale Oct 3, 2024 —
144 Notice of proposed sale Oct 3, 2024 —
144 Notice of proposed sale Oct 3, 2024 —
4 Insider transaction Aug 22, 2024 Aug 20, 2024
144 Notice of proposed sale Aug 21, 2024 —
4 Insider transaction Aug 20, 2024 Aug 19, 2024
4 Insider transaction Aug 20, 2024 Aug 19, 2024
4 Insider transaction Aug 20, 2024 Aug 19, 2024
4 Insider transaction Aug 20, 2024 Aug 19, 2024
144 Notice of proposed sale Aug 19, 2024 —
144 Notice of proposed sale Aug 19, 2024 —
144 Notice of proposed sale Aug 19, 2024 —
144 Notice of proposed sale Aug 19, 2024 —
4 Insider transaction Aug 7, 2024 Aug 5, 2024
4 Insider transaction Aug 7, 2024 Aug 5, 2024
4 Insider transaction Aug 7, 2024 Aug 5, 2024
4 Insider transaction Aug 7, 2024 Aug 5, 2024
144 Notice of proposed sale Aug 6, 2024 —
144 Notice of proposed sale Aug 6, 2024 —
144 Notice of proposed sale Aug 6, 2024 —
144 Notice of proposed sale Aug 6, 2024 —
SC 13G/A Amended ownership over 5% (passive) Aug 2, 2024 —
4 Insider transaction Jul 23, 2024 Jul 19, 2024
4 Insider transaction Jul 23, 2024 Jul 19, 2024
4 Insider transaction Jul 23, 2024 Jul 19, 2024
4 Insider transaction Jul 23, 2024 Jul 19, 2024
144 Notice of proposed sale Jul 22, 2024 —
144 Notice of proposed sale Jul 22, 2024 —
144 Notice of proposed sale Jul 22, 2024 —
144 Notice of proposed sale Jul 19, 2024 —
144 Notice of proposed sale Jul 19, 2024 —
144 Notice of proposed sale Jul 19, 2024 —
144 Notice of proposed sale Jul 19, 2024 —
4 Insider transaction Jul 3, 2024 Jul 2, 2024
4 Insider transaction Jul 3, 2024 Jul 2, 2024
4 Insider transaction Jul 3, 2024 Jul 2, 2024
4 Insider transaction Jul 3, 2024 Jul 2, 2024
144 Notice of proposed sale Jul 2, 2024 —
144 Notice of proposed sale Jul 2, 2024 —
144 Notice of proposed sale Jul 2, 2024 —
144 Notice of proposed sale Jul 2, 2024 —
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction May 23, 2024 May 21, 2024
144 Notice of proposed sale May 21, 2024 —
4 Insider transaction May 21, 2024 May 17, 2024
4 Insider transaction May 21, 2024 May 17, 2024
4 Insider transaction May 21, 2024 May 17, 2024
4 Insider transaction May 21, 2024 May 17, 2024
144 Notice of proposed sale May 17, 2024 —
144 Notice of proposed sale May 17, 2024 —
144 Notice of proposed sale May 17, 2024 —
144 Notice of proposed sale May 17, 2024 —
4 Insider transaction May 7, 2024 May 3, 2024
4 Insider transaction May 7, 2024 May 3, 2024
4 Insider transaction May 7, 2024 May 3, 2024
4 Insider transaction May 7, 2024 May 3, 2024
144 Notice of proposed sale May 3, 2024 —
144 Notice of proposed sale May 3, 2024 —
144 Notice of proposed sale May 3, 2024 —
144 Notice of proposed sale May 3, 2024 —
4 Insider transaction Apr 23, 2024 Apr 19, 2024
4 Insider transaction Apr 23, 2024 Apr 19, 2024
4 Insider transaction Apr 23, 2024 Apr 19, 2024
4 Insider transaction Apr 23, 2024 Apr 19, 2024
144 Notice of proposed sale Apr 22, 2024 —
144 Notice of proposed sale Apr 22, 2024 —
144 Notice of proposed sale Apr 22, 2024 —
144 Notice of proposed sale Apr 19, 2024 —
144 Notice of proposed sale Apr 19, 2024 —
144 Notice of proposed sale Apr 19, 2024 —
144 Notice of proposed sale Apr 19, 2024 —
4 Insider transaction Apr 4, 2024 Apr 2, 2024
4 Insider transaction Apr 4, 2024 Apr 2, 2024
4 Insider transaction Apr 4, 2024 Apr 2, 2024
4 Insider transaction Apr 4, 2024 Apr 2, 2024
144 Notice of proposed sale Apr 2, 2024 —
144 Notice of proposed sale Apr 2, 2024 —
144 Notice of proposed sale Apr 2, 2024 —
144 Notice of proposed sale Apr 2, 2024 —
4 Insider transaction Feb 22, 2024 Feb 20, 2024
4 Insider transaction Feb 22, 2024 Feb 20, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
KLRS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Berkeley Heights, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1754068
Former names
Allovir, Inc. (until Mar 12, 2025); ViraCyte, Inc. (until Oct 2, 2018)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.